LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 83 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2019. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $358,000 | +188.7% | 85,425 | +171.2% | 0.22% | +260.7% |
Q4 2019 | $124,000 | -71.4% | 31,498 | -36.1% | 0.06% | -75.3% |
Q3 2019 | $434,000 | +112.7% | 49,300 | +124.1% | 0.25% | +118.6% |
Q2 2019 | $204,000 | -66.8% | 22,000 | -77.0% | 0.11% | -67.1% |
Q1 2019 | $615,000 | – | 95,607 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |